1 / 1

Non-Small Cell Lung Cancer Market

The Non-Small Cell Lung Cancer market is expected to increase with a CAGR of 10.7% during the study period of 2017-2030.<br>The total Non-Small Cell Lung Cancer incident cases were 484,726 in 7MM in 2017.<br>Increase use of biomarker testing, increase incidence of NSCLC, increase in the mutation-specific trials activity & approval, and competitive landscape are some of the leading factors expected to drive the Non-Small Cell Lung Cancer market in the coming years.<br>The key players in Non-Small Cell Lung Cancer market include Novartis, Merck, KGaA, Eli Lilly and Company, Hoffmann-La Roche, Xcovery, BeyondSpring Pharmaceuticals, OSE Immunotherapeutics, Sanofi, Takeda, AbbVie and others.<br>For more detailed information visit: https://www.delveinsight.com/report-store/non-small-cell-lung-cancer-market<br><br><br>

DelveInsight
Download Presentation

Non-Small Cell Lung Cancer Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related